Mark Froimson

Dr. Mark Froimson is principal of Riverside Health Advisors, with a specialty in financing and accelerating healthcare innovation. In this capacity, he serves as chief medical officer for AngelMD, as chair for the boards of Lazurite and Thrive, and on the boards of Pacira Biosciences, Inc., Sintx Technologies, Inc., and multiple nonprofit organizations, including the National Board of the Arthritis Foundation. He also serves as an advisor to numerous healthcare provider and technology companies.

As executive vice president and chief clinical officer for Trinity Health, Dr. Froimson managed physician, nursing and pharmacy services, quality, safety, patient experience and alternate payment strategies for the clinical enterprise. For 16 years, he was a member of the faculty of the Department of Orthopedic Surgery at the Cleveland Clinic. During that time, he served as president and CEO of Cleveland Clinic’s Euclid Hospital, president of the professional staff of the Cleveland Clinic, vice chair of the Orthopedic and Rheumatologic Institute, and as a member of the Board of Governors and Board of Trustees.